anti-TNF-alpha therapy [topp]
adalimumab [aapp, imft, phsu]
Persistent [tmco]
Improvement [cnce]
Endothelial [tisu]
function [phsf]
progression [patf]
Carotid [bpoc]
Intima media thickness [clna]
Wall [mnob]
Patients [podg]
Rheumatoid Arthritis [dsyn]
Refractory [ftcn]
Conventional Therapy [topp]
treatment [ftcn]
TNF Blocker [moft]
Alpha [inpr]
adalimumab [aapp, imft, phsu]
Persistent [tmco]
Improvement [cnce]
Endothelial [tisu]
function [phsf]
PREVENT [phsu]
morphological [spco]
progression [patf]
Subclinical [qlco]
Atherosclerosis [dsyn]
Patients [podg]
Rheumatoid Arthritis [dsyn]
Refractory [ftcn]
Conventional Therapy [topp]
Series [qnco]
Consecutive [qlco]
Rheumatoid Arthritis [dsyn]
Patients [podg]
Attending [prog]
Outpatient Clinics, Hospital [hcro, mnob]
Switch [mnob]
Antirheumatic Drugs, Disease-Modifying [phsu]
therapy [ftcn]
tnf alpha [aapp, imft]
adalimumab [aapp, imft, phsu]
treatment [ftcn]
Severe [qlco]
Assessed [acty]
Ultrasonography [diap]
techniques [inpr]
Onset [qlco]
adalimumab [aapp, imft, phsu]
therapy [ftcn]
Then [tmco]
Values [qlco]
Flow [npop]
mediated [socb]
Endothelium [tisu]
Dependent [qlco]
Vasodilatation [phsf]
Mean deviation [clna]
Standard [qlco]
Mean deviation [clna]
Standard [qlco]
6 9 [fndg]
Obtained [ftcn]
3 6 [fndg]
P NOS [aapp, imft]
P NOS [aapp, imft]
RESP [clna]
Endothelium [tisu]
Independent [idcn]
Vasodilatation [phsf]
Compared [acty]
Obtained [ftcn]
Observed [ftcn]
Carotid Intima-Media Thickness [clna]
Artery [bpoc]
Wall [mnob]
Values [qlco]
Obtained [ftcn]
Mean deviation [clna]
Standard [qlco]
Compared [acty]
P NOS [aapp, imft]
anti-TNF-alpha therapy [topp]
adalimumab [aapp, imft, phsu]
effects [qlco]
Subclinical [qlco]
Atherosclerosis [dsyn]
Rheumatoid Arthritis [dsyn]
